Network Pharmacology and Molecular Docking‐Based Mechanism Study to Reveal Antihypertensive Effect of Gedan Jiangya Decoction

Abstract excerpt

Primary hypertension is understood as a disease with diverse etiology, a complicated pathological mechanism, and progressive changes. Gedan Jiangya Decoction (GJD), with the patent publication number CN114246896A, was designed to treat primary hypertension. It contains six botanical drugs; however, the underlying mechanism is uncertain. We utilized network pharmacology to predict the active components, targets,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antioxidant Activity and Oxidative Stress
• Share to Natural product bioactivities and synthesis
• Share to Pharmacological Effects of Natural Compounds